---
title: "Sws Hemodialysis Care Co., Ltd. (688410.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688410.SH.md"
symbol: "688410.SH"
name: "Sws Hemodialysis Care Co., Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-19T20:27:22.752Z"
locales:
  - [en](https://longbridge.com/en/quote/688410.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688410.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688410.SH.md)
---

# Sws Hemodialysis Care Co., Ltd. (688410.SH)

## Company Overview

SWS Hemodialysis Care Co., Ltd. provides integrated blood purification solutions for renal failure and critically ill patients internationally. It offers blood purification consumables, chain hemodialysis center medical services, dialysis disposables, and a dialysis center intelligent management system, as well as operates chain dialysis centers. The company also offers blood purification equipment, which includes continuous blood purification equipment, hemodialysis machines, hemoperfusion machines and others.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.swskj.com](https://www.swskj.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: B (0.28)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 22 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 42.53% |  |
| Net Profit YoY | 121.77% |  |
| P/B Ratio | 2.82 |  |
| Dividend Ratio | 0.62% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5159814166.32 |  |
| Revenue | 846465331.32 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 9.17% | B |
| Profit Margin | 19.28% | A |
| Gross Margin | 55.11% | B |
| Revenue YoY | 42.53% | A |
| Net Profit YoY | 121.77% | A |
| Total Assets YoY | 16.58% | B |
| Net Assets YoY | 6.69% | B |
| Cash Flow Margin | 184.66% | B |
| OCF YoY | 42.53% | A |
| Turnover | 0.38 | C |
| Gearing Ratio | 22.96% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Sws Hemodialysis Care Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "42.53%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "121.77%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.82",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.62%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "5159814166.32",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "846465331.32",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "9.17%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "19.28%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "55.11%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "42.53%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "121.77%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "16.58%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "6.69%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "184.66%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "42.53%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.38",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "22.96%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 31.46 | 16/64 | 62.12 | 48.46 | 43.11 |
| PB | 2.80 | 30/64 | 3.02 | 2.87 | 2.70 |
| PS (TTM) | 6.07 | 30/64 | 7.70 | 7.24 | 6.67 |
| Dividend Yield | 0.62% | 33/64 | 0.69% | 0.64% | 0.60% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-30T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 16.08 |
| Highest Target | 22.00 |
| Lowest Target | 22.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688410.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688410.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688410.SH/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**